Your browser doesn't support javascript.
loading
Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells.
Teng, Pang-ning; Bateman, Nicholas W; Darcy, Kathleen M; Hamilton, Chad A; Maxwell, George Larry; Bakkenist, Christopher J; Conrads, Thomas P.
Afiliação
  • Teng PN; Women's Health Integrated Research Center at Inova Health System, Department of Defense Gynecologic Cancer Center of Excellence, Annandale, VA 22003, USA.
  • Bateman NW; Women's Health Integrated Research Center at Inova Health System, Department of Defense Gynecologic Cancer Center of Excellence, Annandale, VA 22003, USA.
  • Darcy KM; Women's Health Integrated Research Center at Inova Health System, Department of Defense Gynecologic Cancer Center of Excellence, Annandale, VA 22003, USA.
  • Hamilton CA; Women's Health Integrated Research Center at Inova Health System, Department of Defense Gynecologic Cancer Center of Excellence, Annandale, VA 22003, USA; Gynecologic Oncology Service, Department of Obstetrics and Gynecology, Walter Reed National Military Medical Center, Bethesda, MD, USA.
  • Maxwell GL; Women's Health Integrated Research Center at Inova Health System, Department of Defense Gynecologic Cancer Center of Excellence, Annandale, VA 22003, USA; Department of Obstetrics and Gynecology, Inova Fairfax Hospital, Fairfax, VA, USA.
  • Bakkenist CJ; Department of Radiation Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
  • Conrads TP; Women's Health Integrated Research Center at Inova Health System, Department of Defense Gynecologic Cancer Center of Excellence, Annandale, VA 22003, USA. Electronic address: conrads@whirc.org.
Gynecol Oncol ; 136(3): 554-61, 2015 Mar.
Article em En | MEDLINE | ID: mdl-25560806

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Cisplatino / Inibidores de Proteínas Quinases / Proteínas Mutadas de Ataxia Telangiectasia / Neoplasias dos Genitais Femininos / Antineoplásicos Idioma: En Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Cisplatino / Inibidores de Proteínas Quinases / Proteínas Mutadas de Ataxia Telangiectasia / Neoplasias dos Genitais Femininos / Antineoplásicos Idioma: En Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos